{"id":54987,"date":"2025-10-24T08:00:12","date_gmt":"2025-10-24T15:00:12","guid":{"rendered":"https:\/\/www.salk.edu\/?post_type=disclosure&p=54987"},"modified":"2025-10-24T09:33:54","modified_gmt":"2025-10-24T16:33:54","slug":"how-hivs-shape-shifting-protein-reveals-clues-for-smarter-drug-design","status":"publish","type":"disclosure","link":"https:\/\/www.salk.edu\/de\/news-release\/how-hivs-shape-shifting-protein-reveals-clues-for-smarter-drug-design\/","title":{"rendered":"Wie das formver\u00e4ndernde Protein von HIV Hinweise f\u00fcr die Entwicklung intelligenterer Medikamente liefert"},"content":{"rendered":"

LA JOLLA\u2014The rate of HIV infection continues to climb globally. Around 40 million people live with HIV-1, the most common HIV strain. While symptoms can now be better managed with lifelong treatment, there is no cure to fully eliminate the virus from the body, so patients still often struggle with related health issues, side effects, social stigma, and drug resistance.<\/p>\n

One of the most promising treatment avenues is disrupting HIV replication by impairing the function of integrase, a protein named for its role in integrating viral genetic material into the human host genome. However, scientists have recently noticed that integrase does more than just integration. Later in HIV\u2019s replication cycle, integrase interacts with viral RNA to help the virus spread and infect new cells.<\/p>\n

\"From<\/a>
From left: Hye Jeong Shin, Gennavieve Gray, Dmitry Lyumkis, Tao Jing, and Zelin Shan.
Klicken Sie hier<\/a> f\u00fcr ein hochaufl\u00f6sendes Bild.
Kredit: Salk Institut<\/figcaption><\/figure>\n

Taking on these two distinct roles\u2014first with DNA, then RNA\u2014requires changes to integrase\u2019s protein structure. Salk Institute researchers recently captured these important structural changes for the first time, creating novel 3D models of integrase in both roles. Now, scientists can connect the dots between integrase\u2019s form and function to begin developing compounds that could impair distinct functions of integrase and, in turn, better treat people living with HIV.<\/p>\n

The new study was published in Nature Communications <\/em><\/a>on October 24, 2025, and was funded by both federal research funding from the National Institutes of Health and private philanthropy.<\/p>\n

\u201cWe are just now finding that these integrase proteins that we have studied for years perform unexpected functionalities, like interacting with RNA,\u201d says senior author Dmitry Lyumkis, PhD<\/a>, an associate professor and holder of the Hearst Foundations Developmental Chair at Salk. \u201cDetermining how integrase interacts with RNA will help us better understand this new role and inform the design of novel and more effective HIV therapeutics.\u201d<\/p>\n

 <\/p>\n

Paving the way for new integrase-targeting drugs<\/strong><\/p>\n

When a virus infects a cell, it inserts its genetic material (DNA or RNA) into the host genome and hijacks the cell\u2019s machinery to make more of the virus. Traditional RNA viruses must bring their own RNA replication tools because the cells are only designed to replicate DNA. However, HIV is a retrovirus, meaning it can reverse-engineer DNA from RNA. Once it has infected a cell, the virus uses that RNA to create complementary viral DNA, which it then inserts into the cell\u2019s own genome. From there, the cell becomes an HIV factory\u2014churning out new viral RNA that gets packaged and sent off to infect more cells.<\/p>\n

Integrase performs the DNA-insertion process, which is a hallmark of the viral replication cycle, making the protein an obvious target for HIV-1 drugs like Dolutegravir. However, HIV-1 evolves rapidly and is prone to developing drug resistance. In 2023, Lyumkis discovered how integrase adapts its structure to evade Dolutegravir<\/a>.<\/p>\n

Studying the mechanisms of drug resistance is one way to cope with HIV-1\u2019s rapid evolution. Another way is to develop new drugs that target new processes. Instead of targeting integrase during DNA insertion, future drugs could instead target integrase during its recently discovered second role: interacting with the newly produced viral RNA as it\u2019s packaged into nascent viruses that have left the cell.<\/p>\n

 <\/p>\n

Two distinct structures reveal integrase\u2019s surprising flexibility<\/strong><\/p>\n

“Very little is known about what integrase is doing in the later stages of HIV replication,\u201d says co-first author Tao Jing, PhD, a postdoctoral researcher in Lyumkis\u2019s lab. \u201cOur use of cryo-electron microscopy to discover the architecture of integrase during this mysterious period is a significant step for HIV research.\u201d<\/p>\n

Cryo-electron microscopy allows researchers to see a protein\u2019s 3D structure as it occurs in nature. Just like a building\u2019s architecture informs its function (think of a movie theater\u2019s layout versus a restaurant\u2019s), a protein\u2019s architecture informs its function, too. With a structural blueprint of a protein in hand, scientists can begin imagining how it works and envisioning compounds that would fit into its structure to enhance or inhibit it.<\/p>\n

The researchers used cryo-electron microscopy to collect two distinct integrase structures: 1) the form that integrates the viral DNA into the host cell\u2019s genome, and 2) the form that likely interacts with the newly produced viral RNA later in the HIV replication process.<\/p>\n

\"On<\/a>
On the left is integrase in its \u201cintasome\u201d structure of four identical four-part complexes (pink) that connect to create one 16-part complex that locks around viral DNA (blue). On the right is integrase in its simpler four-part complex (pink), as it interacts with viral RNA (green) inside an HIV capsid.
Klicken Sie hier<\/a> f\u00fcr ein hochaufl\u00f6sendes Bild.
Kredit: Salk Institut<\/figcaption><\/figure>\n

First, they determined integrase\u2019s architecture as it forms the \u201cintasome\u201d\u2014a special assembly of proteins and viral DNA, depicted above on the left. In this intasome form, integrase is made up of four identical four-part complexes that connect to create one 16-part complex. This huge structure encircles the viral DNA, holding it in place to facilitate its integration with the host genome.<\/p>\n

Second, they determined integrase\u2019s more mysterious protein architecture as it interacts with RNA, seen above on the right. At this point, the protein ditches the giant sixteen-part complex in favor of a simpler, smaller four-part complex. Based on this four-part structure, the team has an idea of how integrase might interact with RNA, and they are planning follow-up studies to confirm their suspicions.<\/p>\n

Integrase is a highly adaptable protein, capable of building up into a 16-part complex, then breaking back down into a four-part complex. Lyumkis says this flexibility is surprising, and though some of the structural changes are subtle, they can make substantial differences in the drug development process.<\/p>\n

\u201cWe\u2019ve created the first blueprints for integrase\u2019s structure during these crucial steps in HIV replication,\u201d says co-first author Zelin Shan, PhD, a postdoctoral researcher in Lyumkis\u2019s lab. \u201cNow we can use those blueprints to design new drugs that suit this structure and disrupt the destructive HIV-1 invasion and replication process.\u201d<\/p>\n

Other authors include Avik Biswas, Zeyuan Zhang, Gennavieve Gray, Hye Jeong Shin, Bo Zhou, Dario Passos, Timothy S. Strutzenberg, Sriram Aiyer, Leonardo Andrade, and Yuxuan Zhang of Salk; Tung Dinh and Mamuka Kvaratskhelia of University of Colorado School of Medicine; Sooin Jang and Alan Engelman of Dana-Farber Cancer Institute and Harvard Medical School; Juliet Greenwood and Zhen Li of Dana-Farber Cancer Institute; and Min Li and Robert Craigie of the National Institute of Diabetes and Digestive Diseases.<\/p>\n

The work was supported by the National Institutes of Health (U01 AI136680, R01 AI146017, U54 AI170855, R01 AI184419, R37 AI039394, U54 AI170791, Intramural Program of the NIDDD, NCI CCSG P30 CA014195, R01 GM151305, GM148049-03, P41 GM103311, S10OD032467), Margaret T. Morris Foundation, Hearst Foundation, Salk Pioneer Fellowship, and Eric and Wendy Schmidt Foundation.<\/p>","protected":false},"featured_media":54993,"template":"","faculty":[320],"disease-research":[457,122],"class_list":["post-54987","disclosure","type-disclosure","status-publish","has-post-thumbnail","hentry","faculty-dmitry-lyumkis","disease-research-hiv","disease-research-immune-system-biology"],"acf":[],"yoast_head":"\nHow HIV\u2019s shape-shifting protein reveals clues for smarter drug design - Salk Institute for Biological Studies<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.salk.edu\/de\/news-release\/how-hivs-shape-shifting-protein-reveals-clues-for-smarter-drug-design\/\" \/>\n<meta property=\"og:locale\" content=\"de_DE\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"How HIV\u2019s shape-shifting protein reveals clues for smarter drug design - Salk Institute for Biological Studies\" \/>\n<meta property=\"og:description\" content=\"LA JOLLA\u2014The rate of HIV infection continues to climb globally. Around 40 million people live with HIV-1, the most common HIV strain. While symptoms can now be better managed with lifelong treatment, there is no cure to fully eliminate the virus from the body, so patients still often struggle with related health issues, side effects, social stigma, and drug resistance.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.salk.edu\/de\/news-release\/how-hivs-shape-shifting-protein-reveals-clues-for-smarter-drug-design\/\" \/>\n<meta property=\"og:site_name\" content=\"Salk Institute for Biological Studies\" \/>\n<meta property=\"article:modified_time\" content=\"2025-10-24T16:33:54+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.salk.edu\/wp-content\/uploads\/2025\/10\/25-lyumkis-pr-homepage.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"767\" \/>\n\t<meta property=\"og:image:height\" content=\"767\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data1\" content=\"6 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.salk.edu\\\/news-release\\\/how-hivs-shape-shifting-protein-reveals-clues-for-smarter-drug-design\\\/\",\"url\":\"https:\\\/\\\/www.salk.edu\\\/news-release\\\/how-hivs-shape-shifting-protein-reveals-clues-for-smarter-drug-design\\\/\",\"name\":\"How HIV\u2019s shape-shifting protein reveals clues for smarter drug design - Salk Institute for Biological Studies\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.salk.edu\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.salk.edu\\\/news-release\\\/how-hivs-shape-shifting-protein-reveals-clues-for-smarter-drug-design\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.salk.edu\\\/news-release\\\/how-hivs-shape-shifting-protein-reveals-clues-for-smarter-drug-design\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.salk.edu\\\/wp-content\\\/uploads\\\/2025\\\/10\\\/25-lyumkis-pr-homepage.jpg\",\"datePublished\":\"2025-10-24T15:00:12+00:00\",\"dateModified\":\"2025-10-24T16:33:54+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.salk.edu\\\/news-release\\\/how-hivs-shape-shifting-protein-reveals-clues-for-smarter-drug-design\\\/#breadcrumb\"},\"inLanguage\":\"de-DE\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.salk.edu\\\/news-release\\\/how-hivs-shape-shifting-protein-reveals-clues-for-smarter-drug-design\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"de-DE\",\"@id\":\"https:\\\/\\\/www.salk.edu\\\/news-release\\\/how-hivs-shape-shifting-protein-reveals-clues-for-smarter-drug-design\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.salk.edu\\\/wp-content\\\/uploads\\\/2025\\\/10\\\/25-lyumkis-pr-homepage.jpg\",\"contentUrl\":\"https:\\\/\\\/www.salk.edu\\\/wp-content\\\/uploads\\\/2025\\\/10\\\/25-lyumkis-pr-homepage.jpg\",\"width\":767,\"height\":767},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.salk.edu\\\/news-release\\\/how-hivs-shape-shifting-protein-reveals-clues-for-smarter-drug-design\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.salk.edu\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"How HIV\u2019s shape-shifting protein reveals clues for smarter drug design\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.salk.edu\\\/#website\",\"url\":\"https:\\\/\\\/www.salk.edu\\\/\",\"name\":\"Salk Institute for Biological Studies\",\"description\":\"The Power of Science\",\"publisher\":{\"@id\":\"https:\\\/\\\/www.salk.edu\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.salk.edu\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"de-DE\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/www.salk.edu\\\/#organization\",\"name\":\"Salk Institute for Biological Studies\",\"url\":\"https:\\\/\\\/www.salk.edu\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"de-DE\",\"@id\":\"https:\\\/\\\/www.salk.edu\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"http:\\\/\\\/www.salk.edu\\\/wp-content\\\/uploads\\\/2023\\\/03\\\/salk_logo_696.jpg\",\"contentUrl\":\"http:\\\/\\\/www.salk.edu\\\/wp-content\\\/uploads\\\/2023\\\/03\\\/salk_logo_696.jpg\",\"width\":696,\"height\":696,\"caption\":\"Salk Institute for Biological Studies\"},\"image\":{\"@id\":\"https:\\\/\\\/www.salk.edu\\\/#\\\/schema\\\/logo\\\/image\\\/\"}}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"How HIV\u2019s shape-shifting protein reveals clues for smarter drug design - Salk Institute for Biological Studies","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.salk.edu\/de\/news-release\/how-hivs-shape-shifting-protein-reveals-clues-for-smarter-drug-design\/","og_locale":"de_DE","og_type":"article","og_title":"How HIV\u2019s shape-shifting protein reveals clues for smarter drug design - Salk Institute for Biological Studies","og_description":"LA JOLLA\u2014The rate of HIV infection continues to climb globally. Around 40 million people live with HIV-1, the most common HIV strain. While symptoms can now be better managed with lifelong treatment, there is no cure to fully eliminate the virus from the body, so patients still often struggle with related health issues, side effects, social stigma, and drug resistance.","og_url":"https:\/\/www.salk.edu\/de\/news-release\/how-hivs-shape-shifting-protein-reveals-clues-for-smarter-drug-design\/","og_site_name":"Salk Institute for Biological Studies","article_modified_time":"2025-10-24T16:33:54+00:00","og_image":[{"width":767,"height":767,"url":"https:\/\/www.salk.edu\/wp-content\/uploads\/2025\/10\/25-lyumkis-pr-homepage.jpg","type":"image\/jpeg"}],"twitter_card":"summary_large_image","twitter_misc":{"Est. reading time":"6 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/www.salk.edu\/news-release\/how-hivs-shape-shifting-protein-reveals-clues-for-smarter-drug-design\/","url":"https:\/\/www.salk.edu\/news-release\/how-hivs-shape-shifting-protein-reveals-clues-for-smarter-drug-design\/","name":"How HIV\u2019s shape-shifting protein reveals clues for smarter drug design - Salk Institute for Biological Studies","isPartOf":{"@id":"https:\/\/www.salk.edu\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.salk.edu\/news-release\/how-hivs-shape-shifting-protein-reveals-clues-for-smarter-drug-design\/#primaryimage"},"image":{"@id":"https:\/\/www.salk.edu\/news-release\/how-hivs-shape-shifting-protein-reveals-clues-for-smarter-drug-design\/#primaryimage"},"thumbnailUrl":"https:\/\/www.salk.edu\/wp-content\/uploads\/2025\/10\/25-lyumkis-pr-homepage.jpg","datePublished":"2025-10-24T15:00:12+00:00","dateModified":"2025-10-24T16:33:54+00:00","breadcrumb":{"@id":"https:\/\/www.salk.edu\/news-release\/how-hivs-shape-shifting-protein-reveals-clues-for-smarter-drug-design\/#breadcrumb"},"inLanguage":"de-DE","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.salk.edu\/news-release\/how-hivs-shape-shifting-protein-reveals-clues-for-smarter-drug-design\/"]}]},{"@type":"ImageObject","inLanguage":"de-DE","@id":"https:\/\/www.salk.edu\/news-release\/how-hivs-shape-shifting-protein-reveals-clues-for-smarter-drug-design\/#primaryimage","url":"https:\/\/www.salk.edu\/wp-content\/uploads\/2025\/10\/25-lyumkis-pr-homepage.jpg","contentUrl":"https:\/\/www.salk.edu\/wp-content\/uploads\/2025\/10\/25-lyumkis-pr-homepage.jpg","width":767,"height":767},{"@type":"BreadcrumbList","@id":"https:\/\/www.salk.edu\/news-release\/how-hivs-shape-shifting-protein-reveals-clues-for-smarter-drug-design\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.salk.edu\/"},{"@type":"ListItem","position":2,"name":"How HIV\u2019s shape-shifting protein reveals clues for smarter drug design"}]},{"@type":"WebSite","@id":"https:\/\/www.salk.edu\/#website","url":"https:\/\/www.salk.edu\/","name":"Salk-Institut f\u00fcr biologische Studien","description":"Die Macht der Wissenschaft","publisher":{"@id":"https:\/\/www.salk.edu\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.salk.edu\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"de-DE"},{"@type":"Organization","@id":"https:\/\/www.salk.edu\/#organization","name":"Salk-Institut f\u00fcr biologische Studien","url":"https:\/\/www.salk.edu\/","logo":{"@type":"ImageObject","inLanguage":"de-DE","@id":"https:\/\/www.salk.edu\/#\/schema\/logo\/image\/","url":"http:\/\/www.salk.edu\/wp-content\/uploads\/2023\/03\/salk_logo_696.jpg","contentUrl":"http:\/\/www.salk.edu\/wp-content\/uploads\/2023\/03\/salk_logo_696.jpg","width":696,"height":696,"caption":"Salk Institute for Biological Studies"},"image":{"@id":"https:\/\/www.salk.edu\/#\/schema\/logo\/image\/"}}]}},"ACF":{"hero":"https:\/\/www.salk.edu\/wp-content\/uploads\/2025\/10\/25-lyumkis-pr-header.jpg","line_1":"How HIV\u2019s shape-shifting protein reveals clues for smarter drug design","line_2":"Salk Institute researchers determine structure of HIV protein during newly discovered function, enabling development of better HIV therapeutics","poster_quote":"","gallery":false,"paper_url":"https:\/\/www.nature.com\/articles\/s41467-025-64479-8","journal_title":"Nature Communications","paper_author_list":"Tao Jing, Zelin Shan, Tung Dinh, Avik Biswas, Sooin Jang, Juliet Greenwood, Min Li, Zeyuan Zhang, Gennavieve Gray, Hye Jeong Shin, Bo Zhou, Dario Passos, Timothy S. Strutzenberg, Sriram Aiyer, Leonardo Andrade, Yuxuan Zhang, Zhen Li, Robert Craigie, Alan N. Engelman, Mamuka Kvaratskhelia, Dmitry Lyumkis","doi":"10.1038\/s41467-025-64479-8","paper_title":"Oligometric HIV-1 integrase structures reveal functional plasticity for intasome assembly and RNA binding","subhead":"Salk Institute researchers determine structure of HIV protein during newly discovered function, enabling development of better HIV therapeutics","home_photo":"","listing_photo":"","legacy_boilerplate":[],"hide_boilerplate":[],"disable_date":false,"listing_excerpt":"","descriptive_blurb":"","has_journal_cover":false,"og_image_override":false},"_links":{"self":[{"href":"https:\/\/www.salk.edu\/de\/wp-json\/wp\/v2\/disclosure\/54987","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.salk.edu\/de\/wp-json\/wp\/v2\/disclosure"}],"about":[{"href":"https:\/\/www.salk.edu\/de\/wp-json\/wp\/v2\/types\/disclosure"}],"version-history":[{"count":4,"href":"https:\/\/www.salk.edu\/de\/wp-json\/wp\/v2\/disclosure\/54987\/revisions"}],"predecessor-version":[{"id":55014,"href":"https:\/\/www.salk.edu\/de\/wp-json\/wp\/v2\/disclosure\/54987\/revisions\/55014"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.salk.edu\/de\/wp-json\/wp\/v2\/media\/54993"}],"wp:attachment":[{"href":"https:\/\/www.salk.edu\/de\/wp-json\/wp\/v2\/media?parent=54987"}],"wp:term":[{"taxonomy":"faculty","embeddable":true,"href":"https:\/\/www.salk.edu\/de\/wp-json\/wp\/v2\/faculty?post=54987"},{"taxonomy":"disease-research","embeddable":true,"href":"https:\/\/www.salk.edu\/de\/wp-json\/wp\/v2\/disease-research?post=54987"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}